The human erythrocyte insulin-like growth factor I receptor: characterization and demonstration of ligand-stimulated autophosphorylation
- PMID: 3005355
- DOI: 10.1210/jcem-62-4-692
The human erythrocyte insulin-like growth factor I receptor: characterization and demonstration of ligand-stimulated autophosphorylation
Abstract
To characterize the insulin-like growth factor I (IGF-I) receptor on human erythrocytes, cells were purified from peripheral blood by Ficoll-Hypaque gradient centrifugation and incubated with [125I]IGF-I. Specific binding was maximal at pH 8.0 after 24 h at 4 C and increased linearly with cell number to 3.9 +/- 0.2% (+/- SEM) for 3.0 X 10(9) cells/ml. The Scatchard plot of the binding data was linear, with 7 fmol [125I]IGF-I bound/10(9) cells and an affinity constant (K) of 1.8 X 10(9) M-1. Unlabeled IGF-I inhibited tracer binding half-maximally at 6 ng/ml. Multiplication-stimulating activity (or rat IGF-II) was 40% as potent (ED50, 15 ng/ml), whereas insulin and proinsulin were 30- to 500-fold less potent. A monoclonal antibody to the IGF-I receptor (alpha IR-3) inhibited IGF-I binding by 50% at a 1:1000 dilution and by 80% at a 1:250 dilution. Insulin binding was unaffected by the same dilutions. IGF-I receptor phosphorylation was studied in erythrocyte ghosts prepared by hypotonic lysis and solubilized in 1% Triton. The extract was preincubated with and without 100 ng/ml IGF-I or porcine insulin and incubated with [gamma-32P]ATP in the presence of Mn2+, and the receptor was identified by immunoprecipitation with alpha IR-3 antibody and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. IGF-I stimulated 4-fold the incorporation of 32P into a protein of 95,000 mol wt, which was immunoprecipitated by alpha IR-3; insulin produced a 2-fold stimulation of this protein. This protein corresponds to the beta-subunit of the IGF-I receptor. These data demonstrate that human erythrocytes have specific receptors for IGF-I, and that this IGF-I receptor, like the insulin receptor, undergoes ligand-stimulated autophosphorylation. Thus, analysis of erythrocyte IGF-I binding and receptor phosphorylation may be useful tools for the study of patients with a variety of growth disorders.
Similar articles
-
Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary.J Clin Endocrinol Metab. 1985 Oct;61(4):728-34. doi: 10.1210/jcem-61-4-728. J Clin Endocrinol Metab. 1985. PMID: 2993346
-
Characterization of insulin-like growth factor I receptor on human erythrocytes.J Clin Endocrinol Metab. 1985 Dec;61(6):1066-70. doi: 10.1210/jcem-61-6-1066. J Clin Endocrinol Metab. 1985. PMID: 2997258
-
Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.Endocrinology. 1985 Nov;117(5):2008-16. doi: 10.1210/endo-117-5-2008. Endocrinology. 1985. PMID: 2995005
-
Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.J Clin Endocrinol Metab. 1988 Jan;66(1):173-80. doi: 10.1210/jcem-66-1-173. J Clin Endocrinol Metab. 1988. PMID: 2961785
-
Insulin-like growth factor receptors.J Cell Sci Suppl. 1985;3:39-51. doi: 10.1242/jcs.1985.supplement_3.5. J Cell Sci Suppl. 1985. PMID: 3011825 Review.
Cited by
-
The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor.J Exp Med. 1992 Apr 1;175(4):1081-90. doi: 10.1084/jem.175.4.1081. J Exp Med. 1992. PMID: 1313074 Free PMC article.
-
Metabolic Influences Modulating Erythrocyte Deformability and Eryptosis.Metabolites. 2021 Dec 21;12(1):4. doi: 10.3390/metabo12010004. Metabolites. 2021. PMID: 35050126 Free PMC article. Review.
-
Analysis of a peptide hormone-receptor interaction in the yeast two-hybrid system.Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13063-8. doi: 10.1073/pnas.94.24.13063. Proc Natl Acad Sci U S A. 1997. PMID: 9371800 Free PMC article.
-
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.J Clin Invest. 1989 Nov;84(5):1418-23. doi: 10.1172/JCI114315. J Clin Invest. 1989. PMID: 2553774 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources